Instalab
logoInstalab

Suspected Atrial Fibrillation

Catch a hidden irregular heartbeat in your sleep, before a stroke is the first sign something was wrong.
4.9 (4,174 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Suspected Atrial Fibrillation test?

This test is most useful if any of these apply to you.

Already Wearing a Sleep Tracker
You already wear a device overnight, and this turns those hours of pulse data into a real screen for an arrhythmia you would otherwise miss.
Over 65 With Blood Pressure Issues
Age and hypertension together drive AF risk sharply upward, and overnight wearable screening catches episodes routine office visits miss.
Worried About Stroke Risk
AF is a leading treatable cause of stroke, and roughly one in five AF strokes is the first sign someone even had the arrhythmia.
Managing a Known Heart Condition
If you have heart failure, prior AF, or coronary disease, tracking suspected episodes nightly tells you whether your current plan is actually controlling rhythm.

About Suspected Atrial Fibrillation

About 1 in 5 strokes caused by atrial fibrillation are the first time the person learns they have it. The arrhythmia is often silent, comes and goes, and is easy to miss on a single in-office ECG. A wearable that watches your heart all night long has a different advantage: time. It can flag short, irregular runs of beats that suggest AF (atrial fibrillation) even when you feel nothing.

This reading does not diagnose AF. It is a screening signal that tells you the rhythm during sleep looked irregular enough to warrant a real ECG. If your number is anything above zero, the next step is confirmation, not panic. Used this way, the metric works as an early tripwire for an arrhythmia that quietly raises your stroke risk.

What This Reading Actually Captures

Your wearable uses a light-based sensor on your wrist or finger (called PPG, short for photoplethysmography) to track the rhythm of blood pulsing through your vessels. An algorithm scans for the chaotic, irregularly irregular pattern that is the signature of AF. When it sees enough of that pattern, it logs the time as suspected AF. The number you see is the total duration of those episodes during the monitoring window.

Because this is a sleep-window measurement, it captures rhythm during the longest stretch of the day when you are still and your heart rate is at its baseline. AF can occur at any time of day, but the still, low-noise sleep window gives PPG sensors a better chance of producing a clean trace. PPG-based wearables can pick up the irregular pulse pattern that AF produces with high sensitivity, but the signal still has to be confirmed by an electrical recording (an ECG) before AF is considered diagnosed.

Why Catching AF Matters

AF makes the upper chambers of your heart quiver instead of pumping cleanly. Blood pools, clots form, and clots can travel to the brain. AF is among the most important treatable causes of ischemic stroke, and many people who have a stroke from AF had no prior diagnosis.

Finding AF earlier matters because the standard response (anticoagulation in appropriate candidates, plus rhythm or rate control and risk factor modification) reliably lowers stroke risk. In a large mobile-health study, most participants whose suspected AF was confirmed entered app-supported care, and a high proportion of those at elevated stroke risk were started on anticoagulation.

Stroke and Systemic Embolism

The clearest payoff of detection is at the brain. Long-term implantable monitoring shows that catching AF gets dramatically more sensitive the longer you watch the heart. A single ten-second ECG snapshot catches roughly 1.5% of episodes, while 30 days of continuous monitoring catches about 34%. A wearable worn nightly over weeks or months gets you closer to the long monitoring window that actually finds intermittent AF.

After a stroke or transient mini-stroke (called a TIA), extended monitoring uncovers previously unknown AF in roughly 11 to 15% of patients, climbing toward 30% with three or more years of implantable monitoring. That is why prolonged rhythm watching is now standard after a stroke of unclear cause.

Heart Failure and Cardiovascular Death

AF rarely lives alone. It tends to coexist with high blood pressure, diabetes, sleep apnea, obesity, and heart failure, and it accelerates each of those problems. A meta-analysis of more than 447,000 patients with recently diagnosed AF found that starting rhythm-control treatment early cut the combined risk of death, stroke, heart failure, and acute coronary syndrome by 12%, and lowered heart failure hospitalization by 10%.

In other words, finding AF and acting on it does not just prevent stroke. It changes the trajectory of several common cardiovascular outcomes at once, which is why a wearable signal worth confirming is worth confirming quickly.

How Strong Is This Signal?

Wearable algorithms have improved substantially. In a large smartwatch and wristband study using PPG, 0.23% of users got a suspected AF flag, and roughly 87 to 92% of those flags matched true AF on confirmatory ECG or Holter testing, though only a portion of flagged users completed follow-up. Smartphone-based PPG apps in primary care have reported sensitivity around 96% and specificity around 97% against a 12-lead ECG. Home blood pressure monitors with built-in AF algorithms reach a pooled sensitivity of 0.98 and specificity of 0.92.

What this means for you: a wearable flag is not the same as a diagnosis, but it is a strong enough signal that it should never be ignored, especially if you are over 65 or have other heart risk factors. The probability that a true AF episode is behind a positive wearable reading is high, and the consequences of missing it are large.

When Results Can Be Misleading

  • Atrial flutter mimicking AF: flutter is a different but related arrhythmia that is frequently misclassified as AF on automated reads, especially when the conduction pattern is variable. A confirmatory ECG sorts this out.
  • Motion and poor sensor contact: PPG depends on a clean optical signal. Loose wear, tattoos, or movement during the night can produce noisy traces that the algorithm flags as irregular.
  • Frequent premature beats: extra beats from the upper or lower chambers can create irregular pulse patterns that look like AF to a screening algorithm but are a different finding.
  • Acute illness or recent surgery: in the 30 days after a hospitalization or non-cardiac surgery, AF episodes detected by implanted devices roughly double. A flag during that window may reflect a true but temporary trigger rather than chronic AF.

Why One Night Is Not Enough

AF is famously intermittent. Most early AF is paroxysmal, meaning it comes and goes on its own, often for minutes to hours at a time, days or weeks apart. A single negative night tells you very little. A single positive night tells you a confirmatory ECG is needed. The real value of this metric comes from trending nights over weeks and months.

A practical cadence: if your wearable flags suspected AF even once, get a confirmatory ECG promptly. If confirmed, follow the treatment plan and use the wearable to track whether episodes are becoming less frequent. If unconfirmed, keep wearing the device and look for repeat flags, particularly if you have stroke risk factors. Pay attention to changes in flag frequency over time rather than to any single night in isolation.

What to Do With an Out-of-Pattern Reading

A confirmed positive wearable flag should trigger a real workup, not a wait-and-see. The first step is a 12-lead ECG or extended ambulatory monitoring (a patch monitor for 1 to 2 weeks, or longer if the suspicion is high). Companion blood work that helps frame the picture includes NT-proBNP (a marker of cardiac strain), hs-CRP (inflammation), thyroid function, and a basic metabolic panel including kidney function, since kidney function shapes anticoagulant choice.

If AF is confirmed, your stroke risk should be formally calculated, anticoagulation should be discussed, and a cardiologist or electrophysiologist should be involved if rhythm control or ablation is on the table. If AF is not confirmed but the wearable keeps flagging, push for longer monitoring. The pattern that should never go unfollowed is a wearable flag plus any of the following: prior stroke or TIA, age over 75, hypertension, diabetes, or heart failure. That combination warrants aggressive workup rather than reassurance.

What Moves This Biomarker

Evidence-backed interventions that affect your Suspected Atrial Fibrillation level

↓ Decrease
Weight loss in overweight or obese adults
Carrying extra weight pushes AF risk up sharply, and losing it pushes risk back down, which should mean fewer flagged episodes on a wearable. The 2023 ACC/AHA guideline gives a Class I recommendation for weight loss of at least 10% in overweight or obese patients with AF to reduce symptoms, burden, recurrence, and progression. Post-ablation lifestyle programs that included weight loss reduced AF frequency and duration.
LifestyleStrong Evidence
↓ Decrease
Early rhythm-control therapy after a new AF diagnosis
If your AF is confirmed and treated early with rhythm-control drugs or ablation, your wearable should pick up fewer flagged episodes over time. A meta-analysis of patients with recently diagnosed AF found early rhythm control cut the combined risk of death, stroke, heart failure, or acute coronary syndrome by about 12%, stroke or systemic embolism by 22%, and heart failure hospitalization by 10%.
MedicationModerate Evidence
↓ Decrease
SGLT2 inhibitors (a class of diabetes drugs)
These drugs lower the chance of developing AF in the first place, which should translate to fewer suspected-AF flags on a wearable. A meta-analysis of 16 randomized trials in adults with type 2 diabetes found a lower risk of AF or atrial flutter and a reduction in all-cause mortality.
MedicationModerate Evidence
↓ Decrease
Supervised exercise or cardiac rehabilitation
Structured exercise programs cut how often AF returns and how much time you spend in it, which should reduce the duration of flagged episodes a wearable picks up. Pooled analyses of patients with AF show a meaningful reduction in AF recurrence and AF burden after 6 to 12 months of supervised training.
ExerciseModerate Evidence
↓ Decrease
Intensive blood pressure control (targeting systolic below 130 mmHg)
Pushing systolic blood pressure under 130 mmHg lowers your chance of developing new AF, so the wearable should flag less suspected AF over time. Observational data in hypertensive adults link tighter systolic control to substantially lower new-onset AF risk.
LifestyleModerate Evidence
↓ Decrease
Comprehensive risk-factor and lifestyle program after ablation
Bundled programs combining weight loss, alcohol reduction, exercise, and management of sleep apnea and blood pressure reduce AF episodes after ablation, which should translate to fewer wearable flags. A systematic review of trials in post-ablation patients found meaningful drops in AF frequency and duration over study periods of several months to a year.
LifestyleModerate Evidence
↓ Decrease
ACE inhibitors and ARBs (blood pressure drugs that block the renin-angiotensin system)
These drugs slow the structural remodeling of the upper heart chambers that drives AF. Pooled analyses of large randomized trials have found modest reductions in new-onset AF risk in primary prevention, with stronger effects in patients who already had AF and were being treated to prevent recurrence or who had heart failure.
MedicationModest Evidence
↓ Decrease
Antihypertensive therapy generally
Lowering blood pressure with any class of drug modestly reduces the chance of developing AF, which should mean fewer wearable flags over time. A meta-analysis of large-scale randomized antihypertensive trials found a modest overall reduction in AF risk, with a larger effect in patients who also had heart failure.
MedicationModest Evidence

Frequently Asked Questions

Panels containing Suspected Atrial Fibrillation

Suspected Atrial Fibrillation is included in these pre-built panels.

References

19 studies
  1. Joglar J, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal a, Eckhardt L, Goldberger Z, Gopinathannair RCirculation2023
  2. Davidson K, Barry M, Mangione C, Cabana M, Caughey a, Davis E, Donahue KE, Doubeni CAJAMA2022
  3. Lubitz S, Atlas S, Ashburner JM, Lipsanopoulos a, Borowsky LH, Guan W, Khurshid S, Ellinor P, Chang Y, Mcmanus D, Singer DECirculation2021
  4. Guo Y, Wang H, Zhang H, Liu T, Liang Z, Xia YJournal of the American College of Cardiology2019